Comparison Chart Ligand Pharmaceuticals Incorporated

LGND

US53220K5048

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	LIGAND PHARMACEUTICALS INCORPORATED	Other Pharmaceuticals	+2.73%	+6.71%	+66.49%	+68.64%	+137.80%	6.11B

10-19	BridgeBio, Madrigal, Cytokinetics Trade Lower Ahead of Q3 Results Amid Lack of Near-Term Catalysts, BofA Says	MT
10-19	BofA Securities Adjusts Price Target on Ligand Pharmaceuticals to $406 From $388, Maintains Buy Rating	MT

Market Closed - Nasdaq 23:00:00 21/10/2026 +03			5-day change	1st Jan Change
314.78 ^USD	+2.73%		+6.71%	+66.49%

Comparison Chart Ligand Pharmaceuticals Incorporated

Stocks

LGND

US53220K5048

Pharmaceuticals

Compared values